MYD88 and neoplasm: Accumulating evidence indicates that the IL-1R/MyD88 signaling axis regulates programmed death-1 (PD-1) expression, thereby sustaining the immunosuppressive activity of TAMs and facilitating tumor progression in melanoma and other malignancies (81, 82).